Es un factor de riesgo de numerosas enfermedades | 11 MAY 20

Psoriasis: no solo la piel

Es un factor de riesgo para enfermedades cardiovasculares, síndrome metabólico y enfermedad vascular periférica, enfermedad intestinal inflamatoria, tumores malignos y nefropatías
Autor/a: Bilal J, Malik SU, Bin Riaz I Kurtzman DJB The American Journal of Medicine (2018)
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. 2016;2:16082.

2. Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205-12.

3. Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. Journal of the American Academy of Dermatology. 2014;70(3):512-6.

4. Carrascosa JM, Rocamora V, Fernandez-Torres RM, Jimenez-Puya R, Moreno JC, Coll-Puigserver N, et al. Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications. Actas dermo-sifiliograficas. 2014;105(1):31-44.

5. Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: Epidemiology. Journal of the American Academy of Dermatology. 2017; 76(3):377-90.

6. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic Arthritis. The New England journal of medicine. 2017;376(10):957-70.

7. Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H. Incidence of psoriasis in children: a population-based study. Journal of the American Academy of Dermatology. 2010;62(6):979-87.

8. Crawford GM. Psoriasis of the nails. Archives of Dermatology and Syphilology. 1938;38(4):583- 94.

9. Langenbruch A, Radtke MA, Krensel M, Jacobi A, Reich K, Augustin M. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. The British journal of dermatology. 2014;171(5):1123-8.

10. Armstrong AW, Schupp C, Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology (Basel, Switzerland). 2012; 225(2):121-6.

11. Klaassen KM, van de Kerkhof PC, Pasch MC. Nail psoriasis: a questionnaire-based survey. The British journal of dermatology. 2013; 169(2):314-9.

12. Tan ES, Chong WS, Tey HL. Nail psoriasis: a review. American journal of clinical dermatology. 2012;13(6):375-88.

13. Ritchlin CT, Colbert RA, Gladman DD. Psoriatic Arthritis. The New England journal of medicine. 2017;376(21):2095-6.

14. Moll JM, Wright V. Psoriatic arthritis. Seminars in arthritis and rheumatism. 1973;3(1):55-78.

15. Rouzaud M, Sevrain M, Villani AP, Barnetche T, Paul C, Richard MA, et al. Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J Eur Acad Dermatol Venereol. 2014; 28 Suppl 5:17-26.

16. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis & Rheumatism. 2006;54(8):2665-73.

17. Gisondi P, Tinazzi I, El-Dalati G, Gallo M, Biasi D, Barbara LM, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Annals of the rheumatic diseases. 2008; 67(1):26-30.

18. Brockbank JE, Stein M, Schentag CT, Gladman DD. Dactylitis in psoriatic arthritis: a marker for disease severity? Annals of the rheumatic diseases. 2005; 64(2):188-90.

19. Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2015; 73(2):242-8.

20. Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. Journal of the American Academy of Dermatology. 2008; 58(5):851-64.

21. Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI. Ocular psoriasis. Journal of the American Academy of Dermatology. 2011; 65(6):1202-12.

22. Chandran NS, Greaves M, Gao F, Lim L, Cheng BCL. Psoriasis and the eye: Prevalence of eye disease in Singaporean Asian patients with psoriasis. The Journal of Dermatology. 2007;34(12):805-10.

23. MD* TS. Ocular Manifestations of Psoriasis. Available from: https://www.ecronicon.com/ecop/pdf/ECOP-05-00142.pdf. Accessed 2018 Mar 21.

24. Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies. Journal of the American Heart Association. 2013; 2(2).

25. Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. The British journal of dermatology. 2007; 157(1):68-73.

26. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. The British journal of dermatology. 2009;161(1):1-7.

27. Ahlehoff O, Gislason GH, Charlot M, Jorgensen CH, Lindhardsen J, Olesen JB, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Journal of internal medicine. 2011; 270(2):147-57.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023